scholarly journals Enlarged inflammatory multiple ground-glass nodules of the lung over five years' follow-up: A surgical case report

2015 ◽  
Vol 29 (7) ◽  
pp. 890-895
Author(s):  
Naoya Yokomakura ◽  
Hiroo Nishijima ◽  
Masakazu Yanagi ◽  
Kazuhiro Wakida ◽  
Aya Harada ◽  
...  
2016 ◽  
Vol 89 (1058) ◽  
pp. 20150556 ◽  
Author(s):  
Mingzheng Peng ◽  
Zhao Li ◽  
Haiyang Hu ◽  
Sida Liu ◽  
Binbin Xu ◽  
...  

2014 ◽  
Vol 03 (11) ◽  
pp. 616-620
Author(s):  
Takuro Yukawa ◽  
Katsuhiko Shimizu ◽  
Yuji Hirami ◽  
Riki Okita ◽  
Shinsuke Saisho ◽  
...  

2019 ◽  
Vol 61 (2) ◽  
pp. 175-183
Author(s):  
Hai Xu ◽  
Xue-Hui Pu ◽  
Tong-Fu Yu ◽  
Hai-Bin Shi ◽  
Yan-Ling Wu ◽  
...  

Background Increased use of thin-section computed tomography (CT) scans has revealed that small lung nodules, termed ground-glass nodules, are frequent in primary breast cancer patients and are associated with pre-invasive or invasive pulmonary adenocarcinomas. However, little is known of the incidence and fate of ground-glass nodules. Purpose To elucidate the incidence and natural course of CT-detected pulmonary ground-glass nodules in Chinese women with breast cancer. Material and Methods We retrospectively reviewed data from female breast cancer patients who underwent lung CT scans and who were followed for ≥3 months after the initial scan to identify the incidence of ground-glass nodules and any changes in them during the follow-up period. Results Between January 2008 and April 2018, 693 out of 4682 breast cancer patients (14.8%) had persistent lung ground-glass nodules as detected by CT scan. The median age was 52 years (interquartile range [IQR] = 45–62 years). Median nodule size was 4.9 mm in diameter on initial CT scan. Frequency of growth was 7.5% (52/693 patients). Median volume doubling time was 1092 days (IQR = 719–1808 days) for 39 growing in size nodules. Initial nodule size, nodule type, and follow-up period were independent predictors of nodule growth. Conclusion Most pulmonary ground-glass nodules in breast cancer patients were stable during long-term follow-up; most growing nodules had an indolent clinical course, suggesting that nodules should be monitored until growth is detected. This information is clinically relevant for accurate diagnosis of cancer stage and for appropriate treatment plans for patients with lung ground-glass nodules.


2019 ◽  
Vol 30 (2) ◽  
pp. 744-755 ◽  
Author(s):  
Lin-Lin Qi ◽  
Bo-Tong Wu ◽  
Wei Tang ◽  
Li-Na Zhou ◽  
Yao Huang ◽  
...  

2020 ◽  
Author(s):  
Takamasa Hotta ◽  
Yukari Tsubata ◽  
Akari Tanino ◽  
Mika Nakao ◽  
Yoshihiro Amano ◽  
...  

Abstract Background Multiple synchronous ground glass nodules (GGNs) are known to be malignant but progress slowly. Multiple synchronous lesions in the same patient show independent characteristics and must be treated individually. Methods This was a retrospective review of 34 lung adenocarcinoma patients with multiple synchronous GGNs in an Asian population. One hundred twenty-seven single lung adenocarcinoma patients were included for comparison. The follow-up period was 5 years for all patients. Results The 5-year overall survival (OS) patients with multiples did not differ from that of patients with single lesion to a statistically significant extent (Single: 81.8% vs. Multiple: 88.2%, P = 0.3602). Dominant tumors (DTs) with a ground glass component and consolidation were divided into three categories based on the consolidation-to-tumor ratio on radiological imaging. No significant differences were observed among the three DT categories. Twenty-four patients had unresected GGNs, progression of the unresected GGN occurred in 10 of these cases. The OS and disease-free survival (DFS) curves of patients with and without GGN progression did not differ to a statistically significant extent (OS: 80% vs. 92.9%, P = 0.3870; DFS: 80% vs. 100%, P = 0.0977). Conclusions The outcomes were best predicted by the stage of the DT. After surgery patients require careful follow-up because unresected GGNs may progress. At the same time, the increase in residual lesions and the appearance of new GGNs were not related to OS. The management should be determined by the DT with the worst prognosis.


Sign in / Sign up

Export Citation Format

Share Document